SUMMARY
Three separate sets of polymerase chain reaction primers were designed to specifically detect the presence of a toxin A gene fragment, a toxin B gene fragment, and the entire toxin B gene. In addition toxin gene fragments that were amplified from well characterized toxic strains were tagged fluorescently and used as hybridization probes to screen C. difficile strains. A survey of 37 toxic strains and 10 non-toxic strains demonstrated that toxic strains normally contain the genetic composition for toxin A and toxin B simultaneously; whereas, non-toxic strains typically did not contain detectable toxin determinants. The only exception found was strain 39, which had the genetic composition for toxins A and B, but was not cytotoxic under the conditions tested. 
INTRODUCTION
Clostridium difficile, which is the causative agent of antibiotic associated pseudomembranous colitis (PMC) in humans, produces two toxins, A and B. The production of toxin A and B may vary considerably in different strains ranging from very high levels of the toxins, to the apparent absence of the toxin proteins or activity [1, 2] . Whereas non-toxic strains do not have detectable toxins, toxic strains of C. difficile appear to possess both the toxin A protein and toxin B activity simultaneously [1, 2] . It also has been suggested that the hemorrhagic enterotoxin A and the potent cytotoxin B act synergistically to induce colitis and PMC [3] .
At the genetic level it has been reported that 
High molecular mass chromosomal DNA isolation
High molecular mass chromosomal DNA was isolated by growing the C. difficile cells for 24 to 48 h in brain heart infusion media supplemented with 1.6% glycine. The cells were spun down at 3000 × g and suspended in TE buffer. A 1:1 mixture of phenol and chloroform was added and then the microcentrifuge tubes were heated for 2 min at 60°C prior to centrifugation. Two chloroform extractions were performed followed by ethanol precipitation. The high molecular mass DNA was suspended in TE buffer.
Cytotoxic assays
The standard cytotoxicity and antibody neutralization assays were performed to test toxin activity using chinese hamster ovary (CHO) cells as described previously [8, 9] . Toxic activity was expressed as the greatest dilution that caused 50% cell death. Toxin antiserum was generated from purified toxin as described previously [10] .
DNA hybridization and electrophoresis
DNA dot blot analysis and Southern blot hybridization were performed using chemiluminescence labeled probes. Approximately 600 ng of PCR amplified DNA was labeled using the procedure outlined in the ECL TM chemiluminescence kit (Amersham, Arlington Heights, IL, U.S.A.). The DNA samples were blotted onto a nitrocellulose membrane using a dot blot apparatus or from a 1% agarose gel. Hybridization was conducted under high stringency conditions (42°C and 0.5 M NaC1) overnight as described in the ECL protocol.
Non-denaturing and denaturing polyacrylamide gel electrophoresis (PAGE) was performed in 5-15% gradient slab gels at pH 8.3 [11] . Electrophoretic transfer (Western blotting) of proteins from polyacrylamide gels to nitrocellulose paper was performed as described by Towbin et al. [12] .
Oligonucleotide primers
The primers used for PCR were toxA-P1 (GGAAATTTAGCTGCAGCATCTGAC), toxA-P2 (TCTAGCAAATTCGCTTGTGTTGAA), toxB-P4 (AGGTGAACTACTGTGCATTC), the degenerative primer toxB-P3 (GAAAAA-ATGGC(T)or(A)AATGT), toxB-P1 (GGTGATA-TGGAGGCATCACCACTAG) and toxB-P2 (TC-CAGGATAAGTCTCCTCTACGTTG). All oligonucleotides were synthesized on a Milligen model 7500 DNA synthesizer.
Amplification of the toxin A and toxin B genes
Amplification of the C. difficile toxin A gene fragment, the toxin B gene fragment, and the entire toxin B gene was carried out in a 50 /tl reaction volume containing 50 ng of C. difficile DNA, 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgC12, 2.5 units of Taq polymerase (Perkin Elmer, Norwalk, CT, USA), 200 ~M dNTP rrfix, and oligonucleotide primers. The primer concentration of toxA-P1 and toxA-P2 used to amplify the toxin A gene fragment was 0.2 uM. A concentration of 0.15 #M was used for the toxB-P1 and toxB-P2 primers, while a primer concentration of 1.84 ttM was used for toxB-P3 and toxB-P4.
To ensure that all nuclease activity was destroyed, the reaction tube was heated for 5 min at 94°C prior to adding the Taq polymerase. Amplification was conducted for 37 cycles for all toxin genes using a Perkin Elmer Cetus thermocyler (Norwalk, CT, U.S.A.). The cycle used to amplify the 1.2-kb toxin A gene fragment consisted of denaturation at 94°C for 1 min, annealing at 55 °C for 1 min, and extension at 65 °C for 1 min. The 1-kb toxin B gene fragment was amplified using a cycle that consisted of a 1-min, denaturation step at 94°C, annealing at 41°C for 1 min, and extension at 72°C for 1 min. The entire toxin B gene was amplified using a cycle that consisted of denaturation for 1.25 min at 94°C, annealing for 2.25 min at 41°C, and extension at 62°C for 10 rain. At the conclusion of the PCR cycles, all tubes were incubated for 7 min at 72°C to allow the amplification process to go to completion. 77 
7. Isolation of toxin A using rabbit erythrocyte ghosts
Rabbit erythrocyte ghosts were prepared using the procedure of Krivan et al. [13] . Toxin A from strains 63 and 10463 was isolated using rabbit erythrocyte membranes as described by Wilkins and Krivan [14] , and generally outlined as follows. Erythrocyte ghosts were mixed with concentrated C. difficile supernatant containing toxin A for 3 h at 4°C, washed 3 times, and incubated at 37°C for 1 h to dissociate the bound toxin A from the erythrocyte membranes.
RESULTS

Toxins A and B screening
Three separate sets of primers were designed to specifically detect the presence of a toxin A gene fragment, and the entire toxin B gene, as well as a toxin B gene fragment. The first set of primers, toxA-P1 and toxA-P2, was derived from the published toxin A gene sequence [15, 16] . These primers amplified a 1216 bp fragment from toxigenic strains, but did not amplify DNA from non-toxigenic strains as seen in Fig. 1A . This pattern of c Primers toxB-P3 and toxB-P4 were used for amplification.
Toxin B 1.0-kb fragment was used as a probe.
n, not analyzed.
amplification held true for 28 toxigenic strains and five non-toxic strains with only one exception, the non-toxic strain 39 amplified the toxin A gene fragment ( Table 1 ). The PCR data described above correlated with DNA hybridization patterns from 37 toxic and 9 non-toxic strains of C. difficile (Table 1) . The fluorescent toxin A probe used for the dot blot hybridizations of HindlII digested chromosomal DNA, was generated by amplifying the 1.2-kb toxin A fragment with toxA-P1 and toxA-P2 from toxigenic strain 9689. All toxin-positive strains tested hybridized with this probe, and the only toxin-negative strain which gave a positive hybridization signal was strain 39 ( Table 1) .
The second set of primers, toxB-P3 and toxB-P4, demonstrated that the entire 7.1 kb toxin B open reading frame could be amplified from toxigenic strains of C. difficile (Fig. 1B) . The toxB-P4 primer was chosen from a sequence down stream of the toxin B gene [15] ; and the degenerate primer toxB-P3 was derived from the N-terminal amino acid sequence [17] of toxin B using the codon usage frequency determined from the published toxin A sequence [15] and CAT-D sequence [18] of C. difficile. ToxB-P3 was synthesized and tested prior to the recently published DNA sequence of toxin B [19] and contained either base A or T in position no. 12. (Position no. 12 was subsequently shown by Barroso et al. to be an A [19] ). Despite this degeneracy, the entire toxin B gene amplified from the 15 toxic strains tested, and did not amplify from 5 non-toxic strains( Table 1) . The non-toxic strain 39 again was the exception (Table  1) .
To demonstrate that the proposed 7.1 kb toxin B open reading frame, that was amplified with the primers toxB-P3 and toxB-P4, did not represent non, specific amplification, primers toxB-P1 and toxB-P2 were designed from tIie recently published toxin B gene sequence [t,9] , These two primers wet~e used to amplify a i~9 bp probe from toxin slrain 10463, which was then Southern blot hybridized to the toxB-P3 : toxBTP4 amplified DNA (Fig. 1D) . As illustrated in Fig. 1D , using the toxic strain 9689, the 1.0-kb toxin B probe only bound to the 7.1-kb amplified fragment. The 1.0-kb toxB-P1 :toxB-P2 probe was also used to hybridize to the DNA of 35 cytotoxin-positive strains, and to verify that this DNA fragment was not present in 7 non-toxic strains, except strain 39 (Table 1) .
Mutant strains
Upon screening for toxin A and B genetic determinants and the activity of toxin B, as well as the immunological presence of toxin A, two mutant toxin strains were identified. The first mutant strain 39 appears to contain the entire toxin B gene as demonstrated by PCR amplification of the 7.1-kb DNA fragment, but lacked cytotoxic activity under the conditions tested for toxin B (Table  1 ). This strain also contained the 1.2-kb toxin A DNA fragment (Table 1) , but preliminary Western blot screening did not show evidence of the production of the toxin A protein. Additional characterization of this mutant is a major emphasis of our research laboratory.
The second mutant that was identified was strain 63. This cytotoxic strain has the genetic determinants for toxin B and at least part of the toxin A gene (Table 1) . However, Western blot data demonstrated that this strain contained a 
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toxin A gene product that migrated at a faster rate in non-denaturing gels than the purified toxin A or toxin A from other strains of C. difficile (Fig.   2) . Preliminary binding and cytotoxic data were obtained on this mutant toxin A protein by subjecting the supernatant of strain 63 (and a control strain 10463) to the erythrocyte ghost purification procedure. This crude preparation demonstrated cytotoxic activity for tissue culture cells which could be neutralized with toxin A antiserum; thus providing preliminary evidence that the mutant toxin contains carbohydrate binding and cytotoxic activities.
DISCUSSION
It has been previously established that toxigenic strains of C. difficile contain the toxin A gene, while non-toxigenic strains do not [4] [5] [6] . To date, a survey for the toxin B genetic composition in toxic and non-toxic strains has not been reported. Also, the toxin B gene has been shown in strain 10463 to be located 1350 bp from the toxin A gene [15] ; therefore, the two genes may be on the same operon. In this study a survey of 37 toxic strains and 10 non-toxic strains demonstrated that in the cytotoxic strains studied the toxin A and B genes were found; whereas non-cytotoxic strains typically did not contain detectable toxin determinants. The only exception found was strain 39, which had the genetic composition for toxin A and B, but did not exhibit cytotoxicity under the conditions tested. The results of this study support the hypothesis that the toxin genes could be part of an operon, since the toxin genes occurred simultaneously in the strains analyzed. For strain 39, it could be suggested that a mutation affecting transcription may exist in the leader sequence of the toxin B gene.
Ongoing characterization of mutant strain 39 may provide future information which will aid in the understanding of toxin gene regulation in C. diffi'cile. The identification of additional mutants, such as strain 63, should provide a foundation for studies aimed at the elucidation of the molecular, biochemical and physiological mechanism of action of toxin-induced PMC.
